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MaOBJECTIVES The purpose of this study was to assess the performance of cardiac magnetic resonance (CMR) methods
for discriminating acute from chronic myocardial infarction (MI).
BACKGROUND Although T2-weighted CMR is thought to be accurate in differentiating acute from chronic MI, few
studies have reported on diagnostic accuracy, and these generally compared extremes in infarct age (e.g., <1 week old vs.
more than 6 months old) and did not evaluate other CMR methods that could be informative.
METHODS A total of 221 CMR studies were performed at various time points after ST-segment elevation myocardial
infarction in 117 consecutive patients without a history of MI or revascularization enrolled prospectively at 2 centers.
Imaging markers of acute MI (<1 month) were T2 hyperintensity on double inversion recovery turbo spin echo (DIR-TSE)
images, microvascular obstruction (MO) on delayed-enhancement CMR, and focally increased end-diastolic wall thickness
(EDWT) on cine-CMR.
RESULTS The prevalence of T2-DIR-TSE hyperintensity decreased with infarct age but remained substantial up to 6
months post-MI. In contrast, the prevalence of both MO and increased EDWT dropped sharply after 1 month. T2-DIR-TSE
sensitivity, speciﬁcity, and accuracy for identifying acute MI were 88%, 66%, and 77% compared with 73%, 97%,
and 85%, respectively, for the combination of MO or increased EDWT. On multivariable analysis, persistence of
T2-hyperintensity in intermediate-age infarcts (1 to 6 months old) was predicted by larger infarct size, diabetes, and
better T2-DIR-TSE image quality score. For infarct size $10% of the left ventricle, a simple algorithm incorporating all
CMR components allowed classiﬁcation of infarct age into 3 categories (<1 month old, 1 to 6 months old, and $6 months
old) with 80% (95% conﬁdence interval: 73% to 87%) accuracy.
CONCLUSIONS T2-DIR-TSE hyperintensity is speciﬁc for infarcts <6 months old, whereas MO and increased EDWT are
speciﬁc for infarcts <1 month old. Incorporating multiple CMR markers of acute MI and their varied longevity leads to a
more precise assessment of infarct age. (J Am Coll Cardiol Img 2015;8:669–79) © 2015 by the American College of
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ABBR EV I A T I ON S
AND ACRONYMS
CI = conﬁdence interval
CMR = cardiac magnetic
resonance
CNR = contrast-to-noise ratio
DE-CMR = delayed-
enhancement cardiac magnetic
resonance
DIR-TSE = double inversion
recovery turbo spin echo
EDWT = end-diastolic wall
thickness
IRA = infarct-related artery
LV = left ventricular
MI = myocardial infarction
MO = microvascular
obstruction
STEMI = ST-segment elevation
myocardial infarction
TIMI = Thrombolysis In
Myocardial Infarction
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670distinguish acute from chronic MI (2–4).
However, the time frame for detecting
“acute” T2-weighted CMR changes is unclear,
and, to date, only 3 studies have reported on
diagnostic performance in 54, 50, and 46
patients, respectively (5–7). Moreover, these
studies have the potential limitation of
spectrum bias in that enrolled patients
generally had extremes in infarct age (e.g., <1
week vs. more than 6 months). Hence, the
diagnostic utility of T2-weighted CMR re-
quires additional validation, especially in
patients with intermediate-age infarcts.
Additionally, other CMR markers may be
useful in discriminating acute from chronic
MI, including the presence of microvascular
obstruction (MO) on delayed-enhancement
CMR and focally increased end-diastolic
wall thickness (EDWT) on cine CMR. The
utility of these methods in comparison with
T2-weighted techniques has not been previ-
ously reported.SEE PAGE 680The purpose of the present 2-center study was
to examine the diagnostic performance of CMR
methods in differentiating acute from chronic MI.
Unlike previous reports, we: 1) included patients
with intermediate-age infarcts (1 to 6 months old);
2) compared multiple CMR methods that could be
informative; and 3) incorporated an assessment of
image quality to help distinguish potentially artifac-
tual from true ﬁndings.
METHODS
POPULATION. We prospectively recruited 122 pa-
tients with a ﬁrst-time ST-segment elevation myo-
cardial infarction (STEMI) at 2 centers (Maastricht
University Medical Center, Maastricht, the Nether-
lands; Duke Cardiovascular Magnetic Resonance
Center, Durham, North Carolina). The diagnosis of
STEMI required appropriate cardiac biomarkers with
12-lead electrocardiography showing ST-segment
elevation ($0.2 mV in 2 or more contiguous pre-
cordial leads or $0.1 mV in $2 contiguous limb leads)
(1). Consecutive patients admitted for primary PCI
who agreed to undergo CMR were enrolled. Patients
with previous MI, revascularization, or CMR contra-
indications were excluded. CMR was performed for
research, and results were not used for clinical deci-
sion making. Four patients did not complete CMR
(hemodynamic instability or claustrophobia); 1 had
recurrent MI before CMR and was excluded. Nopatient was excluded because of image quality. The
ﬁnal population consisted of 117 patients. Because of
scheduling, 5 did not undergo scanning for 1 month.
Hence, 112 underwent CMR <1 month after acute MI.
Eighty-six and 23 patients underwent scans 1 to 6
months and $6 months post-AMI, respectively (total
of 221 scans). In patients with multiple scans, there
were no cardiac events between scans. The ethics
board at both sites approved the study; all patients
gave written informed consent.
Admission data including medications were
recorded. Coronary angiograms were reviewed to as-
sess infarct-related-artery (IRA) reperfusion. Throm-
bolysis In Myocardial Infarction (TIMI) ﬂow grade (8)
was scored as follows: 0 ¼ absence of ﬂow; 1 ¼ faint
ﬂow with incomplete ﬁlling; 2 ¼ delayed ﬂow with
complete ﬁlling; 3 ¼ normal ﬂow.
CARDIAC MAGNETIC RESONANCE. Scanners (1.5-T,
Philips Intera, Best, the Netherlands or Siemens
Avanto, Erlangen, Germany) with standard protocols
were used. Cine images were acquired in multiple
short-axis and 3 long-axis views using steady-state
free precession (slice thickness, 6 mm; gap, 4 mm; in-
plane resolution, w1.7  1.4 mm). A short-axis stack
of T2-weighted images encompassing the left ventricle
andmatched in locationwith cine imageswas obtained
using a double inversion recovery turbo spin echo
(DIR-TSE) sequence (repetition time, 2 R-R intervals;
echo time, 100 ms [Philips], 80 ms [Siemens]; slice
thickness, 8 mm; gap, 2 mm; in-plane resolution,
w1.9  1.4) with spectrally selective fat suppression
and vendor-supplied coil-intensity correction. A con-
ventional black-blood sequence was used so that
ﬁndings could be placed in context with previous
studies reporting diagnostic performance (5–7).
Additionally, black-blood sequences are the most
commonly used in clinical practice because they are
commercially available from all magnetic resonance
imaging scanner vendors. Delayed enhancement
imaging was performed using a segmented inversion
recovery sequence, 10 to 20 min after 0.15 to 0.20
mmol/kg gadolinium contrast (gadolinium-dieth-
ylenetriaminepentaacetic acid or gadoversetamide).
IMAGE ANALYSIS. Scans were interpreted in random
order by consensus of 3 observers blinded to patient
identity, clinical data, and CMR date. Three separate
interpretations were performed, weeks apart: ﬁrst,
with only T2-DIR-TSE images available; second, with
only cine-CMR and delayed-enhancement CMR DE-
CMR images available; and third, with all compo-
nents available. Standard quantitative assessments
were performed to measure infarct size and left
ventricular (LV) ejection fraction based on manual
TABLE 1 Baseline Patient Characteristics (N ¼ 117)
Age, yrs 57.8  11.1
Male 98 (83.8)
Clinical history
Coronary artery disease risk factors
Hypertension 49 (41.9)
Diabetes 12 (10.3)
Hypercholesterolemia 47 (40.2)
Positive family history 55 (47.0)
Smoking 91 (77.8)
No. of risk factors 2.2  1.0
Medications during AMI hospitalization
Aspirin 115 (98.3)
Beta-blocker 114 (97.4)
ACE inhibitor 99 (84.6)
Statin 116 (99.1)
Thienopyridine 108 (92.3)
Glycoprotein IIb/IIIa inhibitor 27 (23.1)
Cardiac enzymes*
Peak troponin T, mg/l 5.3  4.4
Peak CK-MB, U/l 177.3  129.5
Cardiac catheterization
No. of diseased vessels†
1 61 (52.1)
2 29 (24.8)
3 27 (23.1)
Infarct-related artery
RCA 55 (47.0)
LAD 42 (35.9)
LCx 20 (17.1)
Pre-procedure TIMI ﬂow grade 3 21 (17.9)
Final TIMI ﬂow grade 3 104 (88.9)
Values are mean  SD or n (%). *Five patients had troponin I measurements.
†Signiﬁcant coronary artery disease deﬁned as >70% stenosis.
ACE ¼ angiotensin-converting-enzyme; AMI ¼ acute myocardial infarction;
CK-MB ¼ creatine kinase-myocardial band; LAD ¼ left anterior descending artery;
LCx ¼ left circumﬂex artery; RCA ¼ right coronary artery; TIMI ¼ Thrombolysis In
Myocardial Infarction.
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671planimetry of DE-CMR and cine-CMR images,
respectively.
Pre-speciﬁed imaging markers. The presence and
location of CMR abnormalities were determined
visually using the 17-segment model. Window and
level were preset according to society guidelines so
that noise was still detectable and infarcted regions
were not overly saturated (9). The following were
used as markers of acute MI: 1) hyperintense
myocardium on T2-DIR-TSE; 2) the presence of MO
on DE-CMR (central hypoenhancement within hy-
perenhancement) (10); and 3) increased EDWT on
cine-CMR (>150% of remote, measured in the
segment with most severe dysfunction). Regional
wall thinning (EDWT <50% of remote) was also
noted. In patients with T2-DIR-TSE hyperintensity
both <1 month and 1 to 6 months post-AMI,
quantitative analysis of signal intensity ratio and
contrast-to-noise ratio (CNR) were performed:
signal intensity (SI) ratio ¼ (mean SIhyperintense area/
mean SIremote area) and CNR ¼ (mean SIhyperintense
area  mean SIremote area)/(1.5  SD of background
signal outside body) (11).
Match with IRA. Angiograms were analyzed blinded to
the identity and CMR to localize the IRA perfusion
territory on the 17-segment model (12). The location
of the CMR abnormality was considered correct if the
number of segments with CMR abnormality within
the IRA was greater than that outside the IRA.
Image quality was graded as follows: 0 ¼ equiv-
ocal: major artifacts, diagnosis uncertain; 1 ¼ satis-
factory: minor artifacts, images interpretable; 2 ¼
excellent: high diagnostic conﬁdence. The presence
and location of slow-ﬂow (nonsuppressed blood
signal adjacent to endocardium) and signal dropout
(myocardial signal similar to noise) artifacts were
scored using the 17-segment model.
STATISTICAL ANALYSIS. Continuous data are re-
ported as mean  SD. Comparisons of continuous data
were made using 2-sample or paired Student t tests.
Comparisons of discrete data were made using chi-
square tests. The prevalence of CMR abnormalities
according to infarct age was assessed using the chi-
square test for trend. McNemar’s test was used
to compare diagnostic performance. To identify
characteristics associated with T2-DIR-TSE hyper-
intensity, univariable logistic regression analysis was
performed. Characteristics with a p value <0.1 were
considered candidates for subsequent multivariable
analysis. Final model variables were determined by
stepwise selection. Statistical tests were 2 tailed; p <
0.05 was considered signiﬁcant (SAS version 9.3, SAS
Institute, Cary, North Carolina).RESULTS
POPULATION. The baseline clinical characteristics
are shown in Table 1 (60% and 40% enrolled at
Maastricht University and Duke University, respec-
tively). Overall, patients had moderate infarct size
(15.7  10.8%) and preserved LV ejection fraction
(48.6  10.3%).
PREVALENCE OF CMR ABNORMALITIES. T2-DIR-TSE
hyperintensity. The prevalence of T2-hyperintensity
was high (88%) during the ﬁrst month post-MI
(Figure 1A). Of the 13 (12%) that did not have T2-
hyperintensity during the ﬁrst month, 12 had small
infarcts (<10% LV) or poor image quality. The preva-
lence of T2-hyperintensity then steadily decreased
with infarct age, but was still 33% for MIs 3 to 6
months old and 17% for MIs $6 months old. After
FIGURE 1 Prevalence of T2-DIR-TSE Hyperintensity at Different Time Points Post-Myocardial Infarction
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(A) All scans. (B) Only scans with T2-hyperintense regions that match the infarct-related artery determined by angiography included. (C) Only scans with satisfactory or
excellent image quality included. T2-DIR-TSE ¼ T2-weighted double inversion recovery turbo spin echo.
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672discounting hyperintense regions that were remote
from the IRA territory and thus likely artifactual,
the prevalence decreased to 4% for MIs $6 months
old, but remained relatively high at 32% for MIs 3 to
6 months old (Figure 1B). Patient examples with
persistent T2-hyperintensity in intermediate-age in-
farcts are shown in Figure 2.
DE-CMR and Cine-CMR. Examples of MO and regionally
increased EDWT are shown in Figure 3A. Even early
post-MI, the prevalence of MO and increased EDWT
were moderate, and both decreased sharply with
infarct age (Figure 3B). In all cases, MO and increased
EDWT were located in the correct IRA territory. The
combination of MO or increased EDWT allowed a
higher detection rate of MIs <1 month old (73% vs.
55% for MO alone and 42% for increased EDWT alone)
without signiﬁcantly increasing the detection rate of
MIs $1 month old. The prevalence of regional wall
thinning steadily increased with infarct age; however,
given that 6% of infarcts <1 week old had wall thin-
ning, it was not an absolute marker of chronic MI, nor
was it sensitive for chronic MI in that only 35% of
infarcts $6 months old had thinning.
Effect of image quality. Of T2-DIR-TSE images, 66%
were graded satisfactory or excellent compared with
92% and 93% for DE-CMR and cine-CMR, respectively(Figure 4A). T2-DIR-TSE slow-ﬂow artifact was usually
apical, whereas signal dropout was often inferolateral;
however, any location could be affected (Figure 4B).
When only scans with satisfactory or excellent
image quality were included, the prevalence of T2
hyperintensity increased for intermediate-age MI
(Figure 1C), whereas it remained low (7%) for MIs $6
months old. There was no effect of DE-CMR and cine-
CME image quality score on the prevalence of MO
and increased EDWT, respectively.
DIAGNOSTIC PERFORMANCE. Table 2 shows the
diagnostic performance of CMR for individual com-
ponents and combinations. When T2-DIR-TSE was
interpreted alone, there was relatively high sensi-
tivity (88%; 95% conﬁdence interval [CI]: 81% to 94%)
but moderate speciﬁcity (66%; 95% CI: 56% to 75%)
for the diagnosis of acute MI (<1 month old). In
contrast, when only delayed-enhancement and cine-
CMR images were available, the ﬁnding of MO and
increased EDWT, individually, had poor sensitivity
(55% and 42%, respectively) but both were very spe-
ciﬁc (98% and 99%, respectively). The combination of
MO or increased EDWT provided a substantial in-
crease in sensitivity (73%; 95% CI: 64% to 81%), while
maintaining a high speciﬁcity (97%; 95% CI: 92% to
99%), which was greater than the speciﬁcity seen for
FIGURE 2 Patient Examples
Examples demonstrating that T2-DIR-TSE hyperintensity (arrows) seen acutely (<1 month) can persist when reimaged 1 to 6 months post-MI.
In all 3, T2-hyperintense regions match the location of DE-CMR hyperenhancement (arrows). DE-CMR ¼ delayed-enhancement cardiac
magnetic resonance; MI ¼ myocardial infarction; T2-DIR-TSE ¼ T2-weighted double inversion recovery turbo spin echo.
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673T2-DIR-TSE (p < 0.001). When all CMR components
were made available during the interpretation,
sensitivity, speciﬁcity, and accuracy were slightly
higher than for T2-DIR-TSE alone (p ¼ 0.16, p ¼ 0.05,
p ¼ 0.02, respectively).
ForMIs<6months old, the speciﬁcity of T2-DIR-TSE
alone was 83% (95% CI: 66% to 99%). The speciﬁcity
rose to 93% (95% CI: 79% to 100%) when considering
only those scans with satisfactory or excellent image
quality. Likewise, the speciﬁcity of T2-DIR-TSE in-
creased to 96% (95% CI: 87% to 100%) when the
complete examination was made available because
T2-hyperintense regions remote from the infarcted
territory (by DE-CMR) were considered artifactual.
PRESENCE OF T2-DIR-TSE HYPERINTENSITY IN
ACUTE MI. Of 112 scans performed <1 month post-MI,
96 had T2-hyperintensity identiﬁed in the correct
IRA territory. Multivariable logistic regression anal-
ysis demonstrated that the presence of increased
EDWT and higher T2-DIR-TSE image quality scorewere associated with successful identiﬁcation of
T2-hyperintensity (Table 3). The presence of MO
was not associated with the identiﬁcation of
T2-hyperintensity in acute MI.
PERSISTENCE OF T2-DIR-TSE HYPERINTENSITY IN
INTERMEDIATE-AGE MI. Eighty-three patients had
scans performed both <1 month and 1 to 6 months
post-MI. The mean extent of T2-hyperintensity was
less on the later scan (4.5  2.7 vs. 1.1  1.8 segments,
p < 0.001). The degree of hyperintensity as measured
by SIR (1.77  0.51 vs. 1.35  0.18, p < 0.001) and
CNR (35.8  23.4 vs. 17.4  11.2, p < 0.001) was also
lower. Multivariable analysis demonstrated that the
presence of diabetes, larger infarct size, and better
T2-DIR-TSE image quality on the 1- to 6-month
scans were independently associated with persis-
tence of T2-hyperintensity in intermediate-age in-
farcts (Table 4).
CLASSIFICATION INTO INFARCT AGE CATEGORIES.
Because T2-DIR-TSE hyperintensity appeared to be
FIGURE 3 Prevalence of MO and Increased EDWT
(A) Example of MO and increased EDWT in patients with 3-day-old inferior myocardial infarction. (B) Prevalence of MO, increased EDWT, and
the combined marker MO or increased EDWT over time. DE-CMR ¼ delayed-enhancement cardiac magnetic resonance; EDWT ¼ end-diastolic
wall thickness; MO ¼ microvascular obstruction.
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674speciﬁc for infarcts <6 months old and MO and
increased EDWT were speciﬁc for infarcts <1 month
old, a simple algorithm incorporating all components
was devised. The presence of MO or increased
EDWT was used to signify MIs <1 month old; the
presence of T2-hyperintensity in the absence of MO or
increased EDWT to indicate MIs 1 to 6 months
old; and the absence of MO or increased EDWT
and T2-hyperintensity to indicate MIs more than
6 months old. Infarct sizes $5% or $10% of LV mass
occurred in 62% or 84% of the population, respec-
tively, and the algorithm was 70% (95% CI: 63% to
77%) or 80% (95% CI: 73% to 87%) accurate in cate-
gorizing infarct age, respectively.
DISCUSSION
Differentiating an MI that is 1 to 2 weeks old from an
MI that is months old is crucial for patient manage-
ment and risk stratiﬁcation. For example, the risk of
sudden death is highest within 30 days after MIamong patients with LV dysfunction; thus, early
implementation of strategies to reduce the risk
of sudden death may be warranted in selected pa-
tients (13). However, primary prevention implantable
cardioverter-deﬁbrillator implantation should not be
performed for at least 40 days post-MI, even in those
with the requisite level of LV dysfunction, in part
because of the dynamic nature of LV functional
improvement in the ﬁrst several weeks after MI (14).
Hence, knowledge of infarct age is essential to follow
contemporary practice guidelines, yet the majority of
acute MI events are clinically unrecognized, pre-
cluding this determination (15).
In this 2-center study of patients with STEMI who
underwent CMR at known time points after a docu-
mented MI, we found that T2-DIR-TSE hyperintensity
in infarcted regions was speciﬁc for infarcts <6
months old, whereas microvascular obstruction and
increased EDWT was speciﬁc for infarcts <1 month
old. Multivariable analysis demonstrated that per-
sistence of T2-hyperintensity in intermediate-age
FIGURE 4 Image Quality
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675infarcts (1 to 6 months old) was predicted by larger
infarct size, the presence of diabetes, and better
T2-DIR-TSE image quality. A simple algorithm was
developed incorporating multiple CMR markers of
acute MI and accounting for their different longevity.
This allowed classiﬁcation of infarct age into 3 spe-
ciﬁc categories (<1 month old, 1 to 6 months old, and
more than 6 months old) rather than just “acute” or
“chronic” categories, and for infarct size $10% of the
left ventricle, the algorithm was found to be accurate
in 80% of cases.
Our ﬁnding that T2-DIR-TSE is 66% speciﬁc for
differentiating MIs <1 month old appears to be at
odds with previous studies. For instance, Abdel-Aty
et al. (5) reported 96% speciﬁcity for discriminating
acute from chronic MI (chronic deﬁned as more than 4
weeks old). Likewise, Stork et al. (6) and O h-Ici et al.
(7) reported 98% and 99% speciﬁcity, respectively.However, it is important to note that these earlier
studies were not designed to evaluate a broad spec-
trum of infarct age. Instead, the focus was on ex-
tremes, comparing MI within days of admission with
infarcts sometimes years older. Speciﬁcally, Abdel-
Aty et al. (5) compared patients with infarcts 4  3
days old versus 17  19 months old, Stork et al. (6)
compared MIs 5  3 days versus 8  3 months old, and
O h-Ici et al. (7) compared MIs 4  1 days old versus
196  39 days old. Hence, given the potential for se-
lection bias, it is possible the reported speciﬁcity
values are overly optimistic.
The primary basis for the low speciﬁcity that we
report using the threshold of <1 month for acute MI is
the observation that T2-DIR-TSE hyperintensity often
persists for several months post-MI (Figures 1 and 2).
From the literature, the duration of T2-hyperintensity
after acute MI is unclear. The few published studies
TABLE 3 Characteristics Associated With the Presence of T2-DIR-TSE Hyperintensity in
MIs <1 Month Old
Univariable Multivariable
OR (95% CI) p Value OR (95% CI) p Value
General
Age 1.01 (0.96–1.06) 0.78
Male 0.72 (0.15–3.45) 0.68
Clinical history
Hypertension 0.92 (0.32–2.67) 0.88
Diabetes *
Hypercholesterolemia 1.38 (0.44–4.29) 0.58
Positive family history of
coronary artery disease
0.85 (0.29–2.44) 0.76
Smoking 1.84 (0.57–5.94) 0.31
No. of risk factors 1.28 (0.75–2.19) 0.37
Cardiac enzymes
Peak troponin T 1.09 (0.94–1.26) 0.25
Peak CK-MB 1.002 (0.998–1.007) 0.33
Cardiac catheterization
Infarct-related artery: RCA 0.37 (0.12–1.14) 0.08
Pre-procedure TIMI
ﬂow grade 3
0.94 (0.60–1.47) 0.78
Final TIMI ﬂow grade 3 †
No. of diseased vessels 0.62 (0.33–1.16) 0.14
CMR
LVEF 1.000 (0.948–1.054) 1.00
Infarct size 1.02 (0.97–1.08) 0.40
MO 1.73 (0.59–5.02) 0.32
Increased EDWT 13.80 (1.75–108.7) 0.013 12.81 (1.57–104.76) 0.017
MO or increased EDWT 4.60 (1.53–13.80) 0.007
T2-DIR-TSE image
quality score
4.01 (1.62–9.88) 0.003 4.09 (1.52–11.02) 0.005
*Cannot be calculated because in the patient group without T2-hyperintensity, none had diabetes. †Cannot be
calculated because in the patient group without T2-hyperintensity, all had TIMI ﬂow grade 3.
CI ¼ conﬁdence interval; LVEF ¼ left ventricular ejection fraction; OR ¼ odds ratio; RCA ¼ right coronary
artery; TIMI ¼ Thrombolysis In Myocardial Infarction; other abbreviations as in Tables 1 and 2.
TABLE 2 Diagnostic Performance of CMR for Detecting Acute (<1 Month Old)
Myocardial Infarction
CMR Abnormality Sensitivity (%) Speciﬁcity (%) Accuracy (%)
Individual components
T2-DIR-TSE hyperintensity 88 (81–94) 66 (56–75) 77 (71–83)
MO 55 (46–65) 98 (94–100) 76 (70–82)
Increased EDWT 42 (33–52) 99 (95–100) 70 (64–76)
Combinations
MO or increased EDWT 73 (64–81) 97 (92–99) 85 (80–89)
T2 or increased EDWT 87 (79–92) 70 (60–78) 78 (72–83)
T2 or MO 92 (85–96) 70 (60–78) 81 (75–86)
All CMR components available
MO or increased EDWT or T2 92 (85–96) 70 (60–78) 81 (75–86)
Values are % (95% conﬁdence interval).
CMR ¼ cardiac magnetic resonance; EDWT ¼ end-diastolic wall thickness; MO ¼ microvascular obstruction;
T2-DIR-TSE ¼ T2-weighted double inversion recovery turbo spin echo.
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676are inconsistent. In 8 canines, Aletras et al. (16)
reported that none of the T2-hyperintense regions
seen at 2 days post-MI were observed at 2 months.
However, Ghugre et al. (17), in a porcine model,
demonstrated persistent T2 elevation in the infarcted
region at 6 weeks post-MI, albeit only 4 animals were
studied at this time-point. Schulz-Menger et al. (18)
showed in 8 patients with hypertrophic cardiomyop-
athy and iatrogenic MI from septal artery emboliza-
tion that infarct-related T2-hyperintensity visible at
28 days had entirely resolved by 90 days in all 8 pa-
tients. In contrast, Mather et al. (19) reported that
73% of patients with a ﬁrst STEMI who underwent
primary percutaneous coronary intervention had
visible T2-hyperintensity at 90 days; Nilsson et al.
(20) suggested that T2-hyperintensity was detectable
even at 1 year, although this occurred only in 3 pa-
tients. Thus, there is discordance in the literature,
and a complicating factor is that the studies are un-
clear as to whether T2-DIR-TSE images were inter-
preted separately or in conjunction with the rest of
the CMR data, nor is it clear whether interpretations
were performed blinded to the CMR study date. In the
present study, the sample size was larger, T2-DIR-TSE
images were interpreted separately from other CMR
data blinded to the study date, image quality was
assessed, and the IRA territory was determined by
coronary angiography to help distinguish true from
artifactual ﬁndings.
We used a conventional black-blood sequence to
obtain T2-weighted images because it is the most
commonly used in clinical practice and has the most
extensive literature (2). Although image quality oc-
casionally can be suboptimal with this sequence, we
believe that T2-hyperintensity by other sequences
may also be speciﬁc for MIs <6 months old for the
following reasons. First, when only scans with bet-
ter image quality were considered, the speciﬁcity of
T2-DIR-TSE hyperintensity for MIs <6 months old
increased to 93% (from 83%). Second, for scans
with better image quality, T2-DIR-TSE hyperin-
tense regions were invariably within the correct
IRA perfusion territory by coronary angiography
and matched the infarct location determined by
DE-CMR. Third, when T2-DIR-TSE images were read
in conjunction with cine and delayed-enhancement
images (complete examination available), so that
apparent T2-hyperintense regions remote from the
infarcted territory could be considered artifactual,
the speciﬁcity of T2-hyperintensity for MIs <6
months old increased to 96%. These ﬁndings sug-
gest that any technical limitations with the T2-
DIR-TSE sequence should not affect the general
interpretation that T2-hyperintensity is speciﬁc for
TABLE 4 Characteristics Associated With Persistence of T2-DIR-TSE Hyperintensity in
Intermediate-Aged MI
Univariable Multivariable
OR (95% CI) p Value OR (95% CI) p Value
General
Age 1.02 (0.98–1.06) 0.45
Male 0.50 (0.16–1.60) 0.24
Clinical History
Hypertension 1.19 (0.48–3.00) 0.71
Diabetes 4.17 (0.96–18.10) 0.06 5.53 (1.13–27.10) 0.035
Hypercholesterolemia 0.91 (0.34–2.40) 0.84
Positive family history of
coronary artery disease
0.69 (0.28–1.72) 0.43
Smoking 1.16 (0.36–3.79) 0.80
Number of risk factors 1.12 (0.69–1.81) 0.65
Cardiac Enzymes
Peak Troponin T 1.09 (0.98–1.21) 0.13
Peak CK-MB 1.003 (1.000–1.007) 0.048
Cardiac catheterization
Infarct Related Artery—RCA 0.32 (0.12–0.80) 0.015
Pre-Procedure TIMI
ﬂow grade 3
0.59 (0.32–1.09) 0.09
Final TIMI ﬂow grade 3 *
Number of diseased vessels 0.62 (0.33–1.16) 0.14
CMR (on baseline scan)
LVEF 0.94 (0.89–0.99) 0.031
Infarct size 1.08 (1.03–1.13) 0.003 1.08 (1.03–1.14) 0.002
MO 3.56 (1.37–9.24) 0.009
Increased EDWT 0.84 (0.34–2.07) 0.71
MO or Increased EDWT 2.57 (0.84–7.85) 0.10
CMR (1–6 months scan)
T2-DIR-TSE Image
Quality Score
2.02 (1.08–3.79) 0.029 2.18 (1.10–4.33) 0.026
*Cannot be calculated because in the patient group without T2-hyperintensity, all had TIMI ﬂow grade 3.
Abbreviations as in Tables 1, 2, and 3.
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677MIs <6 months old because a different sequence
with better image quality would likely result in an
even higher speciﬁcity of T2-hyperintensity for
MIs <6 months old.
The underlying cause of T2-DIR-TSE hyper-
intensity after MI is thought to be edema (2,5). How-
ever, the data in the present study are perhaps not
entirely consistent with this conjecture. In animal
models, myocardial tissue water content increases
markedly within minutes to hours after acute reper-
fused MI (21). In patients, the rapid, near-doubling in
LV EDWT in the setting of acute MI is assuredly the
consequence of increased tissue water (22,23). Hence,
an acute increase in EDWT should provide a quanti-
tative measure of edema. With this in mind, it is
interesting that the time course of increased EDWT
was clearly different from that of T2-DIR-TSE hy-
perintensity in the present study because it was
exceedingly rare for increased EDWT to be present in
infarcts more than 1 month old. This ﬁnding is
consistent with that reported by Ghugre et al. (17),
who demonstrated complete resolution of acutely
thickened myocardium by 4 weeks and, moreover,
found this was matched in time with the resolution of
edema, as veriﬁed by histopathology. Similarly, in a
human postmortem study, Fishbein et al. (24) re-
ported that infarction-related edema and inﬂamma-
tion, which was ubiquitous in the early days after
acute MI, had entirely resolved by 35 days. These
ﬁndings strongly suggest that infarction-related
edema should resolve by 1 month, and T2-DIR-TSE
hyperintensity that persists far beyond this time is
due to a different mechanism. We propose that T2-
DIR-TSE hyperintensity seen 1 to 6 months post-MI,
long after resolution of increased EDWT, reﬂects
a fundamental alteration in underlying tissue, in-
volving vascular, ﬁbroblastic, and collagenous pro-
liferation in replacement of necrotic myocytes (24)
rather than simply excess water content.
Although the sensitivity of T2-DIR-TSE for acute MI
(<1 month old) was relatively high at 88%, this is
lower than that reported by the initial studies. More
recently, Viallon et al. (25) compared a variety of
black-blood and bright-blood T2-weighted sequences
in the setting of a ﬁrst STEMI and also reported a
lower sensitivity in detecting acute MI, with a high of
80% among all sequences. The authors attributed the
lower sensitivity (and the apparent discrepancy with
older reports) to the fact that T2 images were read in
isolation, blinded to all other CMR data, which was
not the case in previous investigations.
It is well established that MO can complicate acute
MI, and this signals a poor prognosis (10). However,
because many acute infarcts do not have MO, it hasnot been thought to be particularly useful for differ-
entiating acute from chronic MI. The results of the
present study corroborate those of earlier reports
regarding the prevalence and time course of MO.
These studies consistently report a prevalence of
w50% in the ﬁrst week after MI (6,26), with a rapid
decrease to near zero within 1 month (17,19). The pre-
sent study, however, is the ﬁrst to suggest that MO and
increased EDWT may be synergistic for the detection
of acute MI. The combination provided higher test
sensitivity without reducing speciﬁcity for the iden-
tiﬁcation of MIs <1 month old (Table 2). From a path-
ophysiological viewpoint, this suggests that although
both phenomena are associated with larger infarct
sizes, the 2 may represent different pathways of post-
infarction injury. Indeed, MO, by virtue of restricting
myocardial tissue level reperfusion, may limit acute
edema (and therefore limit increased EDWT), albeit
with the consequence of reducing cellular inﬁltration
that could speed infarct healing.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Determining whether a MI is recent or chronic is
sometimes difﬁcult, but there are important implica-
tions for patient management and prognosis. A
multicomponent CMR examination involving cine,
T2-weighted imaging, and delayed-enhancement
imaging can help to distinguish between acute,
subacute, and chronic MI.
TRANSLATIONAL OUTLOOK: T2-weighted CMR is
promulgated as an excellent method to noninvasively
identify myocardial edema associated with injury from
a variety of disorders. However, the mechanism of
T2-weighted hyperintensity requires further investi-
gation, given that T2-weighted hyperintensity may
persist for several months after acute MI—long after
the time when edema has resolved.
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678STUDY LIMITATIONS. By leveraging the multiple
CMR markers of acute MI and their different
longevity, we developed a simple algorithm to clas-
sify infarct age as <1 month old, 1 to 6 months old,
and more than 6 months old. We emphasize that this
algorithm should be considered only a guide. In pa-
tients with acute MI but small infarct size (e.g., <10%
of the left ventricle), MO and increased EDWT are
frequently absent. Thus, the presence of T2-DIR-TSE
hyperintensity may reﬂect MIs either <1 month old or
1 to 6 months old, and, accordingly in this situation,
infarct age should be interpreted simply as <6
months old. An additional limitation is that many
infarcts 1 to 6 months old did not have T2-DIR-TSE
hyperintense regions. This was associated with
infarct size; therefore, at present, it appears prudent
to consider small infarcts without T2-DIR-TSE hy-
perintense regions (and without MO and increased
EDWT) simply as more than 1 month old. Despite
this limitation, the lack of persistent T2-DIR-TSE
hyperintensity was also associated with suboptimal
image quality, and it is likely the signiﬁcance of
this limitation will decrease with technical advances
in CMR.
CONCLUSIONS
In this prospective 2-center study, we found that
T2-DIR-TSE is sensitive but not speciﬁc for detecting
MIs <1 month old because T2-hyperintensity often
persists for months. In contrast, the presence of MO
or focally increased EDWT was observed to bespeciﬁc for MIs <1 month old, and, when used in
conjunction with T2-hyperintensity, the combination
frequently provided a more precise assessment of
infarct age.
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